A randomised, placebo-controlled trial of weekly paclitaxel and saracatinib (AZD0530) in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer
McNeish, I.A., Ledermann, J.A., Webber, L., James, L., Kaye, S.B., Hall, M., Hall, G., Clamp, A., Earl, H., Banerjee, S., Kristeleit, R., Raja, F., Feeney, A., Lawrence, C., Dawson-Athey, L., Persic, M., Khan, I.
Published in Annals of oncology (01.10.2014)
Published in Annals of oncology (01.10.2014)
Get full text
Journal Article
Clear cell ovarian cancer (CCOC): Predicting risk of relapse (ROR)
Devlin, M.-J., Ledermann, J.A., Lockley, M., Wilkinson, N., McDermott, J., Kristeleit, R.S., Miller, R.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
A phase I study of daily afatinib, an irreversible ErbB family blocker, in combination with weekly paclitaxel in patients with advanced solid tumours
Suder, A, Ang, J.E, Kyle, F, Harris, D, Rudman, S, Kristeleit, R, Solca, F, Uttenreuther-Fischer, M, Pemberton, K, Pelling, K, Schnell, D, de Bono, J, Spicer, J
Published in European journal of cancer (1990) (01.11.2015)
Published in European journal of cancer (1990) (01.11.2015)
Get full text
Journal Article
Preliminary safety, efficacy, and PK/PD characterization from GARNET, a phase I clinical trial of the anti–PD-1 monoclonal antibody, TSR-042, in patients with recurrent or advanced MSI-H endometrial cancer
Oaknin, A., Ellard, S.L., Leath III, C., Moreno, V., Kristeleit, R., Guo, W., Lu, S., Jenkins, D., McEachern, K., Yu Jen, K., Dunlap, S., Im, E., Gilbert, L.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Phase I/II study of ODM-203, a selective dual FGFR/VEGFR inhibitor, in patients with advanced solid tumours
Bono, P, Massard, C, Peltola, K, Azaro, A, Italiano, A, Kristeleit, R S, Lassen, U N, Arkenau, H-T, Hakulinen, P, Garratt, C, Ikonen, T, Mustonen, M, Rodon, J
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Phase III trial of lurbinectedin versus PLD or topotecan in platinum-resistant ovarian cancer patients: Results of CORAIL trial
Gaillard, S., Oaknin, A., Ray-Coquard, I.L., Vergote, I.B., Scambia, G., Colombo, N., Ghamande, S.A., Soto-Matos, A., Fernandez, C.M., Kahatt, C., Gomez, J., Nieto, A., Torres, N., Pardo-Burdalo, B., Papai, Z., Kristeleit, R.S., O’Malley, D.M., Benjamin, I., Pautier, P., Lorusso, D.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Corrigendum to ‘Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers’: [ESMO Open volume 7 (2022) 10.1016/j.esmoop.2022.100401]
Samani, A., Bennett, R., Eremeishvili, K., Kalofonou, F., Whear, S., Montes, A., Kristeleit, R., Krell, J., McNeish, I., Ghosh, S., Tookman, L.
Published in ESMO open (01.06.2023)
Published in ESMO open (01.06.2023)
Get full text
Journal Article
Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin
PLOQUIN, A, OLMOS, D, VOEST, E. E, SCHÖFFSKI, P, SCHELLENS, J. H, KRAMAR, A, KRISTELEIT, R. S, ARKENAU, H.-T, KAYE, S. B, PENEL, N, LACOMBE, D, A'HERN, R, DUHAMEL, A, TWELVES, C, MARSONI, S, MORALES-BARRERA, R, SORIA, J.-C, VERWEIJ, J
Published in British journal of cancer (25.09.2012)
Published in British journal of cancer (25.09.2012)
Get full text
Journal Article
A phase I, dose escalation, pharmacodynamic, pharmacokinetic, and food-effect study of α2 integrin inhibitor E7820 in patients with advanced solid tumors
Milojkovic Kerklaan, B., Slater, S., Flynn, M., Greystoke, A., Witteveen, P. O., Megui-Roelvink, M., de Vos, F., Dean, E., Reyderman, L., Ottesen, L., Ranson, M., Lolkema, M. P. J., Plummer, R., Kristeleit, R., Evans, T. R. J., Schellens, J. H. M.
Published in Investigational new drugs (01.06.2016)
Published in Investigational new drugs (01.06.2016)
Get full text
Journal Article
Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers
Samani, A., Bennett, R., Eremeishvili, K., Kalofonou, F., Whear, S., Montes, A., Kristeleit, R., Krell, J., McNeish, I., Ghosh, S., Tookman, L.
Published in ESMO open (01.04.2022)
Published in ESMO open (01.04.2022)
Get full text
Journal Article
2746 A Phase 2 open-label, multicenter study of single-agent rucaparib in the treatment of patients with relapsed ovarian cancer and a deleterious BRCA mutation
Shapira-Frommer, R, Oza, A, Domchek, S.M, Balmana, J, Patel, M.R, Chen, L.M, Drew, Y, Burris, H.A, Korach, J, Flynn, M, Bowering, V.L, Morgan, M.A, Watkins, S.P, Simpson, D, Goble, S, Maloney, L, Kristeleit, R
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
2700 Final results of ARIEL2 (Part 1): A phase 2 trial to prospectively identify ovarian cancer (OC) responders to rucaparib using tumor genetic analysis
Kristeleit, R, Swisher, E, Oza, A, Coleman, R.L, Scott, C, Konecny, G, Tinker, A, O'Malley, D.M, Brenton, J, Bell-McGuinn, K, Oaknin, A, Leary, A, Lin, K.K, Raponi, M, Giordano, H, Maloney, L, Goble, S, Yelensky, R, McNeish, I
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
599 Effect of Food On Relative Bioavailability of E7820 in Cancer Patients
Slater, S, Witteveen, P.O, Plummer, R, Kristeleit, R, Evans, T.R.J, Reyderman, L, de las Heras, B, Verbel, D, Ink, B, Schellens, J.H.M
Published in European journal of cancer (1990) (01.11.2012)
Published in European journal of cancer (1990) (01.11.2012)
Get full text
Journal Article
P116 ATHENA (GOG-3020/ENGOT-ov45; EudraCT 2017–004557–17; NCT03522246): a randomised, double-blind, placebo-controlled, phase 3 study of the poly(ADP-Ribose) polymerase (PARP) inhibitor rucaparib + the PD-1 inhibitor nivolumab following frontline platinum-based chemotherapy in ovarian cancer (OC)
Christopoulou, A, Marmé, F, Oaknin, A, Lorusso, D, Safra, T, Lindahl, G, Chudecka-Glaz, A, Ciuleanu, T, Collins, DC, Demirkiran, F, Lifrenko, I, Van Gorp, T, Coleman, RL, Fujiwara, K, Oza, AM, Westin, SN, O’Malley, DM, Herzog, TJ, Eskander, R, Wilson, M, Argire, S, Grechko, N, McNeish, IA, Monk, BJ, Kristeleit, RS
Published in International journal of gynecological cancer (01.11.2019)
Published in International journal of gynecological cancer (01.11.2019)
Get full text
Journal Article
1234 POSTER A First in Man Phase 1 Study of JNJ-26481585, a Novel Oral Histone Deacetylase Inhibitor (HDACi) in Advanced Cancer Patients -Evidence of Target Modulation, Antitumour Activity and Additional Safety Data in an Expanded Patient Cohort
Omlin, A, Venugopal, B, Kristeleit, R, Shah, K, Fourneau, N, Hellemans, P, de Bono, J, Plummer, R, Banerji, U, Evans, J
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
Dose intensity in advanced non-small cell lung cancer
Brunetto, A, Carden, C.P, Ashley, S, Baird, R, Myerson, J, Kristeleit, R, Montes, A, Popat, S, O'Brien, M
Published in Lung cancer (Amsterdam, Netherlands) (2008)
Published in Lung cancer (Amsterdam, Netherlands) (2008)
Get full text
Journal Article